AUSTRALIAN research to uncover the genes that could repair the damage inflicted by multiple sclerosis (MS) will soon be underway.
One of 17 cutting-edge projects to receive funding today from MS Australia's latest $4.5m grant round, the research has the potential to provide significant clues about how progression works at a genetic level, with the ultimate aim of slowing the disease progression in people with MS.
A/Prof Justin Rubio, from The Florey Institute of Neuroscience and Mental Health will spearhead the project and will integrate various genomic data sources, to discover genes involved in progressive MS and how they fit into the MS puzzle.
The above article was sent to subscribers in Pharmacy Daily's issue from 28 Feb 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Feb 24
